Please assess the completion status of the following clinical trial:

Trial Title: Long-Acting Reversible Contraception

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 18 to 29 years of age;~* sexually active;~* seeking oral or injectable contraception;~* working cell phone;~* working email account;~* willingness to be contacted by the clinic staff or study coordinators; and,~* willingness to complete questionnaires.~Exclusion Criteria:~* currently pregnant;~* previous use of a long-acting reversible contraceptive (LARC) method; and,~* medical contraindications for oral contraceptives and injectables.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 29 Years
- Healthy Volunteers: t

Study Arms:
- Preference SARC (Type: OTHER): Participants received one of a variety of oral contraceptives or DMPA
- Randomized LARC (Type: EXPERIMENTAL): Participants receive one of the following interventions:~Implanon® or Nexplanon®; ParaGard®; Mirena®
- Randomized SARC (Type: ACTIVE_COMPARATOR): Participants received one of a variety of oral contraceptives or DMPA

Based on this trial design, predict the completion outcome and termination type (if applicable).